IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q4 2025 Holdings

Filed 2026-02-13 | 3 holdings | $1.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tscan Therapeutics Inc(TCRX)COM89854M101$630.0K630,00043.4%
Barinthus Biotherapeutics PL(BRNS)ADS91864C107$449.6K642,20430.9%
Werewolf Therapeutics Inc(HOWL)COM95075A107$373.2K589,10225.7%